Genetic diagnostics of hematological malignancies has evolved dramatically over the years. from chromosomal banding analysis to next-generation sequencing. with a corresponding increased capacity to detect clinically relevant prognostic and predictive biomarkers. In diagnostics of patients with chronic lymphocytic leukemia (CLL). https://www.truvisionhealthftp.com/